Report description
Antibiotics
are also known as anti-bacterials or antimicrobials. Since the discovery of the
antibiotic penicillin in 1920 antibiotics are used in the treatment of
infections caused by germs-bacteria and certain parasites-via inhibiting the
growth of microorganisms or killing them. Certain factors that
are driving the market growth include the emergence of anti-MRSA drugs,
development of generic drugs, and vulnerable aging population. The global antibiotics market witness growth by the
development of novel approaches for new antibiotics for treating bacterial
infections and a large number of clinical trials also increase in incidence of
infectious diseases such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and
the market scenario of demand and supply of antibiotics are the other factors
propelling the market. The global antibiotics market size is $XXXX million in
2018, and is expected to forecast $ XXXX million by 2024, growing at a CAGR of 1.8%
from 2018 to 2024.
A large
number of players have been focusing on new drug development and clinical
trials. Prominent biotechnology companies are entering into strategic alliances,
which have helped them make considerable investments in drug discovery.
Pharmaceutical companies are developing analogues of existing antibiotic
classes based on innovative approaches to fight bacterial infections. Rising demand for antibiotics to
counter increasing cases of drug-resistant infections, combined with decreasing
Research and Development (R&D) costs, is presenting a
suitable opportunity for pharmaceutical
manufacturers to launch novel products into the marketplace.
The increase in patient assistance programs (PAPs) on the usage and benefits
related to antibiotics will be one of the major factors driving the global antibiotics market growth through 2024,
These programs allow pharmaceutical companies to provide free samples or
discounted medicines to low-income patients and uninsured and under-insured
patients, thus driving antibiotics market demand.
In present the demand for beta lactam & beta lactamase inhibitors
segment generated the highest revenue in 2017 and is anticipated to maintain
its dominance throughout the forecast period. This is attributed to its
broad-spectrum activity, which heals infections caused due to multiple groups of
bacteria. Thus, the demand for beta lactam & beta lactamase inhibitors is
high among the healthcare providers and patients, which in turn fuels the
growth of the global antibiotics market.
Asia-Pacific
represent the large share in the global market in the session of 2017,
accounting for the highest share, and is predicted for maintaining the same
trend in the upcoming forecast period of 2024. This is attributed to increased
consumption of antibiotics, their easy availability, and rise in sale of
over-the-counter drugs.
Antibiotics Market by Product- Cephalosporin antibiotics market
- Penicillin antibiotics market
- Fluroquinilone antibiotics market
- Macrolide antibiotics market
- Carbapenem antibiotics market
- Aminoglycoside antibiotics market
- Sulfonamide antibiotics market
Antibiotics
Market by Application- Human antibiotics market
- Animal antibiotics market
Antibiotics Market by
Chemical Class- Beta-lactam antibiotics market
- Macrolide antibiotics market
- Quinolone antibiotics market
Antibiotics Market by
Mechanism of action- Bacteriostatic antibiotics market
- Bactericidal antibiotics market
Antibiotics Market by
Spectrum- Broad-spectrum antibiotics market
- Narrow-spectrum antibiotics market
Top Players in Global Antibiotic industry
- Abbott Laboratories
- GlaxoSmithKline
Plc
- Allergan Plc.
- Mylan N.V.
- F.Hoffmann-La Roche Ltd.
- Pfizer Inc.
- Merck
& Co. Inc.
- Novartis International AG (Sandoz)
- Sanofi
- Teva
Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Eli Lilly
- Lupin
Pharmaceuticals
- Bayer HealthCare
- Sun Pharmaceutical
- Shionogi
The
report includes complete evaluation of the market via in-depth quantitative
& qualitative insights, secondary & primary verification, historical
data, and market size & forecast. The projections in this report are based
on various methodologies & assumption.
CHAPTER 1 RESEARCH METHODOLOGY
CHAPTER 2 REPORT DESCRIPTION
CHAPTER 3 ANTIBIOTICS EXECUTIVE SUMMARY
CHAPTER 4 ANTIBIOTICS MARKET
OVERVIEW
- 4.1. Antibiotics Drivers
- 4.1.1. Increased regional consumption
in developed & developing countries
- 4.1.2. Development of novel
approaches & Clinical trials
- 4.1.3. Rise in prevalence of
infectious diseases
- 4.2. Antibiotics Opportunity
- 4.2.1. Discovery of advanced
prospect molecules and novel combination therapies
CHAPTER5 GLOBAL ANTIBIOTICS MARKET
SIZE BY CLASS- 5.1. Beta Lactam and Beta Lactamase Inhibitors
- 5.1.1. Penicillin’s
- 5.1.2. Cephalosporin’s
- 5.1.3. Carbapenem’s
- 5.1.4. Monobactam’s
- 5.2. Quinolones
- 5.3. Macrolides
- 5.4. Others
CHAPTER 6 GLOBAL ANTIBIOTICS MARKET
SIZE BY DRUG ORIGIN- 6.1. Overview
- 6.2. Broad-spectrum antibiotic
- 6.3. Narrow-spectrum antibiotic
CHAPTER 7 GLOBAL ANTIBIOTICS MARKET
SIZE BY ROUTE OF ADMINISTRATION- 7.1. Oral
- 7.2. Intravenous
- 7.3. Others
CHAPTER 8 GLOBAL ANTIBIOTICS
REGIONAL MARKET SIZE & MARKET FORECAST- 8.1. Antibiotics Market Overview
In Asia-Pacific (China, India, South Korea, Taiwan & Rest of Asia Pacific Available)
- 8.2. Antibiotics Market Overview
In Europe (Germany, Spain, France, United Kingdom & Rest of Europe Available
- 8.3. Antibiotics Market Overview
In North America (Canada, US, Mexico, Guatemala & Rest of North America Available)
- 8.4. Antibiotics Market Overview
In South America (Paraguay, Bolivia, Peru, Argentina & Rest of South America Available)
- 8.5. Antibiotics Market Overview
In Middle East & Africa (GCC Countries, South Africa, Ghana, Egypt, North Africa& Rest of
MEA Available)
- 8.6. Antibiotics Market Overview
In Australia
CHAPTER9 ANTIBIOTICS CONTINENT
& COUNTRY WISE COMPETITIVE LANDSCAPE ANALYSIS- 9.1. Antibiotics Global
Manufacturer Overview
- 9.2. Antibiotics Top Player
Analysis
- 9.3. Antibiotics Continent Wise
Market Share
- 9.4. Antibiotics Manufacturers
Deliverable Format
CHAPTER 10 ANTIBIOTICS GLOBAL
MARKET SIZE & MARKET GROWTH FORECASTING (2019-2024) ANALYSIS- 10.1. Antibiotics Global Market
Size& Market Growth In Terms of Volume (2015-18)
- 10.2. Antibiotics Global Market
Size& Market Growth In Terms of Value Million USD (2015-18)
- 10.3. Antibiotics Global Market
Size& Market Growth In Terms of Volume (2019-24)
- 10.4 Antibiotics Global Market
Size& Market Growth In Terms of Value Million USD (2019-24)
CHAPTER 11 ANTIBIOTICS WORLDWIDE
SWOT ANALYSIS- 11.1. Antibiotics Strength
Analysis
- 11.2. Antibiotics Weakness Analysis
- 11.3. Antibiotics Opportunity
Analysis
- 11.4. Antibiotics Threat
Analysis
CHAPTER 12 ANTIBIOTICS REPORT
BASED BUSINESS RECOMMENDATION
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
